Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Izotropic Corp (CSE: IZO )

0.2000 -0.0150 (-6.98%)
Official Closing Price Updated: 12:13 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17,975
Open 0.2200
Bid (Size) 0.1800 (5,500)
Ask (Size) 0.2450 (11,500)
Prev. Close 0.2150
Today's Range 0.2000 - 0.2200
52wk Range 0.1800 - 0.8600
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Izotropic Confirms FDA Pre-Submission Meeting Date
Vancouver, BC - TheNewswire - September 27, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (OTC:IZOZF) (FSE:1R3), a medical device company commercializing IzoView, a CT (computed... 
Via TheNewswire.com
Exposures Product Safety
Izotropic Closes Non-Brokered Private Placement
Vancouver, BC - TheNewswire - September 20, 2023 - Izotropic Corporation (“Izotropic” or the “Company”) (CSE: IZO) (OTCQ: IZOZF) (FSE: 1R3), a medical device company commercializing IzoView, a CT... 
Via TheNewswire.com

Performance

YTD
-71.83%
-71.83%
1 Month
-28.57%
-28.57%
3 Month
-25.93%
-25.93%
6 Month
-48.72%
-48.72%
1 Year
-53.49%
-53.49%

More News

Read More
Izotropic Corporation Announces Non-Brokered Private Placement
Via TheNewswire.com
Izotropic Files Class II Pre-Submission with FDA & Releases Details on Predicate Devices
Via TheNewswire.com
Exposures Product Safety
Izotropic Engages Market Awareness Consultant
Via TheNewswire.com
Izotropic Modifies Market Approval Pathway & Strategy
Via TheNewswire.com
Exposures Product Safety
Izotropic Completes QSUB Meeting With FDA Regarding Clinical Study Acceleration
Via TheNewswire.com
Exposures Product Safety
Izotropic Provides Business Update
Via TheNewswire.com
Izotropic to Extend Period for Unsecured Loans
Via TheNewswire.com
Izotropic's Izoview Breast CT Device to be Featured on Advancements TV Show in USA
Via TheNewswire.com
Izotropic Creates Compensation Committee and Adopts Charter
Via TheNewswire.com
Izotropic Releases First Video of IzoView
Via Newsfile
Izotropic Releases First Video of Izoview
Via TheNewswire.com
Izotropic Reports Board Meeting Results
Via TheNewswire.com
Izotropic Delays Announcements to 2023, Holds Board Meeting
Via TheNewswire.com
Izotropic Announces 2022 AGM Results and Clarifies Restating of Financial Statements
Via TheNewswire.com
Izotropic Completes Izoview Development and Assembly, Prepares for Final Testing
Via TheNewswire.com
Alexander Tokman Joins Izotropic Board Of Directors
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
IZOTROPIC CORPORATION Announces Closing of Non-Brokered Private Placement
Via TheNewswire.com
Izotropic Grants Stock Options
Via TheNewswire.com
Izotropic Appoints Medical Device R&D Expert as Executive VP of Product Engineering
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
Izotropic Updates Timelines for Clinical Study and Fabrication of Initial Izoview Units
Via Newsfile
Topics Supply Chain
Exposures COVID-19 Product Safety Supply Chain
Izotropic Provides Corporate Update
Via Newsfile
Exposures COVID-19
Tomosynthesis Pioneer Joins Izotropic Scientific Advisory Board
Via Newsfile
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.